| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |